2022 Annual Meeting | P10 - Poster Session 10

Date Tuesday 04/05/22

Time 08:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Education, Research, and Methodology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, General Neurology, Headache, History of Neurology, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Sports Neurology

CME Available 0.00 CME credit

Program Materials Program Evaluations

Event Timeline
08:00 AM - 09:00 AM PDT	Abstract	9-001 - Adult-onset MELAS Syndrome Mimicking Autoimmune Encephalitis Rumyar V. Ardakani, MD
08:00 AM - 09:00 AM PDT	Abstract	9-002 - DiGeorge Syndrome Associated with Longitudinally Extensive Transverse Myelitis Jenelle Raynowska, MD
08:00 AM - 09:00 AM PDT	Abstract	9-003 - Transverse Myelitis Secondary to Insect Bite: A Case Series and Proposed Pathophysiologic Mechanism Evan Madill, MD
08:00 AM - 09:00 AM PDT	Abstract	9-004 - Title: Faciobrachial Dystonic Seizures in a patient with NMDAR (N Methyl D aspartate receptor) Encephalitis Naga Krishnakanth Madireddy, MD
08:00 AM - 09:00 AM PDT	Abstract	9-005 - Cerebral Calcifications in Systemic Lupus Erythematosus Rishika Singh
08:00 AM - 09:00 AM PDT	Abstract	9-006 - A Subacute Neurologic Presentation of Fibrosing Inflammatory Pseudotumor Mattia Rosso, MD
08:00 AM - 09:00 AM PDT	Abstract	15-001 - Treatment Satisfaction and Optimization With Real-World Use of Ubrogepant for the Acute Treatment of Migraine in Combination With an Anti-Calcitonin Gene–Related Peptide Monoclonal Antibody Preventive: Results From the COURAGE Study Janette Contreras-De Lama
08:00 AM - 09:00 AM PDT	Abstract	15-002 - A Real-World, Observational Study of Erenumab for Migraine Prevention in Canadian Patients With Prior Prophylactic Treatment Failure Driss Rochdi, PhD
08:00 AM - 09:00 AM PDT	Abstract	15-003 - Real-World Effectiveness of Ubrogepant for the Acute Treatment of Migraine When Used in Combination With an Anti-Calcitonin Gene–Related Peptide Monoclonal Antibody Preventive: Results From the COURAGE Study Aubrey Adams, PhD
08:00 AM - 09:00 AM PDT	Abstract	15-004 - Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or CGRP mAbs: A Retrospective Claims Analysis Study Patrick J. Gillard, PharmD, MS
08:00 AM - 09:00 AM PDT	Abstract	15-005 - Bridging the Gap With Gift Bags: Interdepartmental, Multi-Modal Approach to Headache in the Emergency Department Ellen Michelle Gibson, MD
08:00 AM - 09:00 AM PDT	Abstract	15-006 - Use of Anti-CGRP Monoclonal Antibodies to Treat Headache in Patients with Idiopathic Intracranial Hypertension: A Retrospective Study Lindsay Frerichs, MD
08:00 AM - 09:00 AM PDT	Abstract	3-001 - Cognitive Screening Subscores and Cortical Thickness in Amnestic and Non-Amnestic Mild Cognitive Impairment Carolyn Parsey, PhD
08:00 AM - 09:00 AM PDT	Abstract	3-002 - Disrupted white matter microstructural integrity and network connectivity are related to poor cognition functions: data from a large community-based aging population Zi-Yue Liu
08:00 AM - 09:00 AM PDT	Abstract	3-003 - MRI Investigation of Caudate Networks in the Normal Aging Edoardo G. Spinelli, MD
08:00 AM - 09:00 AM PDT	Abstract	3-004 - Greater Functional Connectivity in Right Temporal Cortex was Associated with SuperAging Soo-Hyun Kim, MD
08:00 AM - 09:00 AM PDT	Abstract	3-005 - Longitudinal changes of subcortical volumes in SuperAgers Hyung Ho Kim, MD
08:00 AM - 09:00 AM PDT	Abstract	12-001 - Impact of Vaginal estriol on urogenital symptoms in Relapsing Remitting Multiple Sclerosis Mirla L. Avila, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	12-002 - Reduced Reward Responsiveness: A Unique Phenotypic Presentation of Depressive Symptoms in Multiple Sclerosis Tali R. Sorets
08:00 AM - 09:00 AM PDT	Abstract	12-003 - Sources of Cannabis Information and Medical Guidance Among People With Multiple Sclerosis: NARCOMS Survey Results Robert J. Fox, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	12-004 - Discordance between Neurologists and People With Multiple Sclerosis on the Perception of the Presence and Burden of Cognitive Impairment Daniela Piani Meier
08:00 AM - 09:00 AM PDT	Abstract	12-005 - Validation of Novel Semantic Word-Retrieval Tasks as Sensitive to Word-Finding Difficulty in Multiple Sclerosis Emily Dvorak
08:00 AM - 09:00 AM PDT	Abstract	12-006 - Treating Mild, Moderate, or Severe Spasticity Matters to People with Multiple Sclerosis - SEEN-MSS Survey Scott D. Newsome, DO, FAAN
08:00 AM - 09:00 AM PDT	Abstract	12-007 - Heart Rate Variability (HRV) Corresponds to Multiple Sclerosis Symptom Burden Giuseppina Pilloni, PhD
08:00 AM - 09:00 AM PDT	Abstract	12-009 - Subcortical brain volumes are sexually dimorphic and related to neurofunctional outcomes in MS Victoria Leavitt, PhD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	12-010 - Impact of Social Distancing during the COVID-19 Pandemic on Longitudinal Severity of Depression in Patients with Multiple Sclerosis – A Single Site Analysis Magdalena Lana
08:00 AM - 09:00 AM PDT	Abstract	12-011 - Beyond the Physical Symptoms of Spasticity for People With MS Spasticity: Results From SEEN-MSS, a Large-scale, Self-reported Survey Scott D. Newsome, DO, FAAN
08:00 AM - 09:00 AM PDT	Abstract	6-001 - Eladocagene Exuparvovec Improves Body Weight and Reduces Respiratory Infections in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Paul Wuh-Liang Hwu
08:00 AM - 09:00 AM PDT	Abstract	6-002 - Early Psychotherapy in Post-Concussion Syndrome. A Study in the Pediatric Population and Young Adults. Alcy Torres, MD
08:00 AM - 09:00 AM PDT	Abstract	6-003 - Design and Rationale of SMART, a Phase IIIb Study Evaluating Intravenous Onasemnogene Abeparvovec in Spinal Muscular Atrophy Sandra P. Reyna, MD
08:00 AM - 09:00 AM PDT	Abstract	6-004 - Therapeutic Hypothermia in Neonatal Encephalopathy: Creating a Post-Pandemic Playbook Justin Rosati, MD
08:00 AM - 09:00 AM PDT	Abstract	6-005 - Decision Support for AAN Quality Measures Anup D. Patel, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	7-001 - Standardized Site Description Template Meeting LCME Elements Celia Linton Walker, MHA
08:00 AM - 09:00 AM PDT	Abstract	7-002 - Leadership and Professional Development Innovation in a Military Adult Neurology Residency Program to Enhance Medical Readiness Zahari Tchopev, MD
08:00 AM - 09:00 AM PDT	Abstract	7-003 - Implementing Collaborative, Innovative Trainee-Centered Strategies to Enhance the Mayo Clinic Arizona Neurology Residency Educational Experience Sara Dawit, MD
08:00 AM - 09:00 AM PDT	Abstract	7-004 - A Single-Center Study Surveying Neurology Trainees and Faculty’s Perceptions of the Impact of the COVID-19 Pandemic on Residents’ Medical Education Hisham Alhajala, MD
08:00 AM - 09:00 AM PDT	Abstract	1-001 - Were the Incas Skilled Surgeons? A Comparison of Survival Rates Between Incan and Contemporary Cranial Procedures Jorge A. Cespedes
08:00 AM - 09:00 AM PDT	Abstract	1-002 - The Neurology in Shakespeare Lance Fogan, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	1-003 - “Stranger than fiction”: the nineteenth-century media coverage of the case of Phineas Gage Manon Auffret, PhD, PharmD, DAAN
08:00 AM - 09:00 AM PDT	Abstract	1-004 - Babinski and His Sign Sanem P. Uysal, MD
08:00 AM - 09:00 AM PDT	Abstract	10-001 - Does Tranexamic Acid (TXA) post Traumatic Brain Injury (TBI) return Service Members to the Battlefield? Matthew D. Holtkamp, DO
08:00 AM - 09:00 AM PDT	Abstract	10-002 - Influence of Ethnoracial and Sociodemographic Variables on Incidence and Management of Traumatic Brain Injury Patients in Hawaii
08:00 AM - 09:00 AM PDT	Abstract	10-003 - Clinical Profiles of Concussed U.S. Soldiers Injured During the January 8th, 2020 Iranian Theatre Ballistic Missile Attack on Al Asad Air Base, Iraq: A Real World, Chaotic, Blast-related TBI Mass Causality Event Jeffrey B. Hainsworth, DO
08:00 AM - 09:00 AM PDT	Abstract	10-004 - Standardized Neurologic Exam Findings Following Sports Related Concussion Nicholas S. Streicher, MD
08:00 AM - 09:00 AM PDT	Abstract	10-005 - Traumatic Encephalopathy Syndrome in a cohort of Professional Fighters Charles Bernick, MD
08:00 AM - 09:00 AM PDT	Abstract	10-006 - Menstrual Cycle Function Following Concussion in Adolescent Patients. Patricia R. Roby, PhD
08:00 AM - 09:00 AM PDT	Abstract	10-007 - Stratifying Risk for Failure to Receive Concussion Care Jonathan Davidow, MD
08:00 AM - 09:00 AM PDT	Abstract	4-001 - New Onset Refractory Status Epilepticus secondary to HIV CNS Syndrome Mustafa Al-Chalabi, DO
08:00 AM - 09:00 AM PDT	Abstract	4-003 - A Rare Case of Postherpetic Wallerian Degeneration of the Trigeminal nerve Ademilola Tejuoso
08:00 AM - 09:00 AM PDT	Abstract	4-004 - West Nile Virus Encephalitis with Flaccid Myelitis and Atypical T1 Hyperintensities on Brain Magnetic Resonance Images after Transplant Ada Breitenbucher, MD
08:00 AM - 09:00 AM PDT	Abstract	4-005 - Progressive Multifocal Leukoencephalopathy as the Initial Presenting Sign of Underlying Immune Abnormalities: A Series of 3 Cases. Busranur Agac, MD
08:00 AM - 09:00 AM PDT	Abstract	13-001 - The Bulbar Imposter: A Case Presentation of Foix-Chavany-Marie Syndrome Christina Xia, MD
08:00 AM - 09:00 AM PDT	Abstract	13-002 - Association of Cerebral Microbleeds in ARDS and Acute Vascular Pathology on MRI Aron Gedansky, MD
08:00 AM - 09:00 AM PDT	Abstract	13-003 - When to suspect depression among patients who suffered from stroke Mays Khweileh, Jr., MD
08:00 AM - 09:00 AM PDT	Abstract	13-004 - Consider Holding DAPT Acutely for Patients with Large Strokes Who May Need Procedures Elisabeth B. Marsh, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	13-005 - Effect of non-invasive vagus nerve stimulation in hemorrhagic brain injury and permanent ischemic stroke in rats
08:00 AM - 09:00 AM PDT	Abstract	13-006 - Postpartum Risk of Cerebral Venous Thrombosis Tehniyat Baig, MD
08:00 AM - 09:00 AM PDT	Abstract	13-007 - Venous Thromboembolism Development in Stroke Patients: A Retrospective Analysis of Predictors Youssra H. Saqr, MD
08:00 AM - 09:00 AM PDT	Abstract	13-008 - Management and Outcomes of Stroke in Patients with Parkinson’s Disease Lynda Nwabuobi, MD
08:00 AM - 09:00 AM PDT	Abstract	13-009 - Clinical and Demographic Characteristics Associated With Poor Posterior Circulation Stroke Outcomes: Greater Cincinnati/Northern Kentucky Stroke Study Lina Chervak, MD
08:00 AM - 09:00 AM PDT	Abstract	13-010 - Reversible Ischaemia Without Infarction Presenting as Progressive Hemichorea Sarah Wrigley, MD
08:00 AM - 09:00 AM PDT	Abstract	13-011 - Early-onset delirium after spontaneous intracerebral hemorrhage
08:00 AM - 09:00 AM PDT	Abstract	5-001 - Pharmacokinetics, Pharmacodynamics, and Safety of the Highly Selective Dopamine D1/D5 Agonist Tavapadon: Summary of Phase 1 Clinical Studies Gina Pastino, PhD
08:00 AM - 09:00 AM PDT	Abstract	5-002 - Duration of Benefit Per Dose: Post Hoc Analysis of ”Good On” Time Per Dose for IPX203 vs CD-LD IR in the RISE-PD Phase 3 Trial Robert A. Hauser, MD, MBA, FAAN
08:00 AM - 09:00 AM PDT	Abstract	5-003 - Long-Term Motor Function and Quality of Life Outcomes from a Prospective, International DBS Registry Guenther Deuschl, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	5-004 - SAGE-718 in Parkinson's Disease Mild Cognitive Impairment: Results from the Phase 2 PARADIGM Study (Part A) Aaron Koenig
08:00 AM - 09:00 AM PDT	Abstract	5-005 - SPAN-PD: Subgroup Analyses by Baseline Characteristics of Patients Treated With Levodopa Inhalation Powder 84mg or Placebo to Treat OFF Symptoms in Patients With Parkinson’s Disease (PD) as Measured by Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) Score and Patient Global Impression of Change (PGIC) Stuart H. Isaacson, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	5-006 - Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Results from the ongoing BeyoND study Stuart H. Isaacson, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	5-007 - Monoclonal Antibodies Targeting Alpha Synuclein- a revolutionary treatment for Parkinson’s Disease Harshadayani Jagadish Kumar, MBBS
08:00 AM - 09:00 AM PDT	Abstract	2-001 - Hospital-based Observational Study of Neurological Disorders in Patients Recently Vaccinated with COVID-19 mRNA Vaccines Jasmine Koh, MBBS
08:00 AM - 09:00 AM PDT	Abstract	2-002 - Machine Learning Analysis of Anosmia and Ageusia after COVID-19 Vaccination: A Vaccine Adverse Event Reporting System (VAERS) Study Kranthi K. Mandava
08:00 AM - 09:00 AM PDT	Abstract	2-003 - Dizziness After COVID-19 Infections or Vaccinations Karen Stephenson
08:00 AM - 09:00 AM PDT	Abstract	2-004 - Assessing the Impact of COVID-19 on Clinical Trials within Neurology Veronica E. Santini, MD, MA, FAAN
08:00 AM - 09:00 AM PDT	Abstract	2-005 - A Case of Chronic Inflammatory Demyelinating Polyneuropathy after Pfizer COVID-19 Vaccination. Irma N. Duncan, MD
08:00 AM - 09:00 AM PDT	Abstract	11-001 - No Significant Increase of Guillain-Barré Syndrome after COVID-19 Vaccination in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study Mustafa Jaffry
08:00 AM - 09:00 AM PDT	Abstract	11-002 - Retrospective Cohort Study Evaluating Outcomes in Myasthenia Gravis Patients with COVID-19 Minseon Kim, MD
08:00 AM - 09:00 AM PDT	Abstract	11-003 - Herpes Zoster may be a trigger for Lumbosacral Radiculoplexus Neuropathy Catarina Aragon Pinto, MD
08:00 AM - 09:00 AM PDT	Abstract	11-004 - Electrodiagnostic characteristics of hereditary (hATTR) and wild-type amyloid (wt-TTR) neuropathy Akhil Shivaprasad, MBBS
08:00 AM - 09:00 AM PDT	Abstract	11-005 - Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability Stephen A. Johnson, MD
08:00 AM - 09:00 AM PDT	Abstract	11-006 - Demyelinating Features More Common in Recurrent Guillain-Barré Syndrome: is Monophasic GBS a Different Disease? Adib Jorge De Sarachaga, MD
08:00 AM - 09:00 AM PDT	Abstract	11-007 - Compound Mutations in IGHMBP2 are Associated with a Demyelinating Polyneuropathy Xue Yang, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	11-008 - Hereditary TTR amyloid neuropathy unmasked by bortezomib chemotherapy for multiple myeloma Xiaoyang Li, MD
08:00 AM - 09:00 AM PDT	Abstract	11-009 - Use of Botulinum Toxin in the Treatment of Neuropathic Pain: A Case Series Deep Patel, MD
08:00 AM - 09:00 AM PDT	Abstract	11-010 - Adult-Onset Krabbe Disease Presenting as Demyelinating Neuropathy in a Much Older Adult: A Case Report Aparna Nutakki, MD

Faculty Disclosures
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Phillip A. Low, MD, FAAN	Dr. Low has nothing to disclose.
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Thomas J. Grabowski, MD	The institution of Dr. Grabowski has received research support from NIH.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Brett M. Kissela, MD, MS, FAAN	The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Deborah I. Friedman, MD, MPH, FAAN	Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsone. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a President-elect, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
May Han, MD	Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Raid M. Kofahi, MD	Dr. Kofahi has nothing to disclose.
Wolfgang Singer, MD, FAAN	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Erika Driver-Dunckley, MD, FAAN	Dr. Driver-Dunckley has nothing to disclose.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Kore K. Liow, MD, FACP	The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Jun Li, MD, PhD, FAAN	The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Michelle L. Mauermann, MD, FAAN	The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
XinLi Du, MD	Dr. Du has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx.
Didier Leys, MD, FAAN	The institution of Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Stanley Fisher, MD, FAAN	Dr. Fisher has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Kevin Tan, MD, FAAN	Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Cinzia Cordioli, MD	Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Todd J. Schwedt, MD, FAAN	Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Schwedt has or had stock in Nocira.Dr. Schwedt has or had stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. The institution of Dr. Schwedt has received research support from AbbVie. The institution of Dr. Schwedt has received research support from Flinn Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
Susan Criswell, MD	Dr. Criswell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Chong S. Lee, MD, FRCPC	Dr. Lee has nothing to disclose.
Charles Bernick, MD	Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optina. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corium. Dr. Bernick has stock in Aurora. The institution of Dr. Bernick has received research support from UFC. The institution of Dr. Bernick has received research support from Top Rank Promotions. The institution of Dr. Bernick has received research support from Haymon Boxing.
Kevin Klos, MD	The institution of Dr. Klos has received research support from Sunovion. The institution of Dr. Klos has received research support from Roche. The institution of Dr. Klos has received research support from Impax. The institution of Dr. Klos has received research support from Prilenia. The institution of Dr. Klos has received research support from Enterin.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Sian D. Spacey, MD, MBBS	Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for abbvie. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartits. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lilly. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lilly. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbvie. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Dr. Spacey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lilly.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
William B. Young, MD, FAAN	Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
	No disclosure on file
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Aziz I. Shaibani, MD, FAAN	Dr. Shaibani has nothing to disclose.
Werner Poewe, MD	Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Jaya Trivedi, MD, FAAN	The institution of Dr. Trivedi has received research support from Avidity.
Matthew T. Lorincz, MD, PhD	Dr. Lorincz has received personal compensation for serving as an employee of Alexion. Dr. Lorincz has received personal compensation for serving as an employee of Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Lorincz has received research support from Alexion.
Cornelia Mihai, MD, FAAN	Dr. Mihai has nothing to disclose.
Dawn O. Kleindorfer, MD, FAAN	Dr. Kleindorfer has nothing to disclose.
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Christine L. Lay, MD, FRCP	Dr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Dr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Lay has received research support from Teva. The institution of Dr. Lay has received research support from Lundbeck.
Jonathan P. Gladstone, MD	Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lily. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lily. Dr. Gladstone has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aralez. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Gladstone has received publishing royalties from a publication relating to health care.
Jennifer L. Cox, PhD	Dr. Cox has nothing to disclose.
Amber Salter, PhD	Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Werner J. Becker, MD	Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Discussion moderator / speaker with Pfizer. Dr. Becker has a non-compensated relationship as a Board Member with Migraine Canada that is relevant to AAN interests or activities. Dr. Becker has a non-compensated relationship as a Board Member with Pain Society of Alberta that is relevant to AAN interests or activities.
Gianvito Martino, MD	Dr. Martino has nothing to disclose.
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Khalid I. El-Salem, MD, FAAN	Dr. El-Salem has nothing to disclose.
Sean O'Riordan, MD	Dr. O'Riordan has nothing to disclose.
Joshua R. Steinerman, MD	Dr. Steinerman has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Steinerman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Click Therapeutics. Dr. Steinerman has received stock or an ownership interest from Greenwich Biosciences. Dr. Steinerman has received stock or an ownership interest from Click Therapeutics. Dr. Steinerman has received intellectual property interests from a discovery or technology relating to health care.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Nathan P. Staff, MD, PhD, FAAN	Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Iram Zaman, DO, FAAN	Dr. Zaman has nothing to disclose.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Ben W. Thrower, MD	Dr. Thrower has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Thrower has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Thrower has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Thrower has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Mirla L. Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Carlo S. Tornatore, MD	Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Sebastiano Bucello, MD	Dr. Bucello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bucello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Roberta Lanzillo	Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Kerry L. Knievel, DO, FAAN	Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . The institution of Dr. Knievel has received research support from Abbvie .
Tracey Cho, MD, FAAN	Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Emanuele D'Amico	Emanuele D'Amico has nothing to disclose.
Patrick J. Gillard, PharmD, MS	Mr. Gillard has received personal compensation for serving as an employee of AbbVie. Mr. Gillard has stock in AbbVie.
Paul Wuh-Liang Hwu	Paul Wuh-Liang Hwu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics Inc.. Paul Wuh-Liang Hwu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. The institution of Paul Wuh-Liang Hwu has received research support from PTC therapeutics.
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Babak Navi, MD	Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Laurence Salin	Laurence Salin has received personal compensation for serving as an employee of NeuroDerm.
Nissim Sasson	No disclosure on file
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Robert Chinnapongse, MD	Dr. Chinnapongse has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Chinnapongse has stock in Greenwich Biosciences.
James T. Eckner, MD	An immediate family member of Dr. Eckner has received personal compensation for serving as an employee of Autism Alliance of Michigan. The institution of Dr. Eckner has received research support from NIH. The institution of Dr. Eckner has received research support from Department of Defense. Dr. Eckner has received intellectual property interests from a discovery or technology relating to health care. Dr. Eckner has received personal compensation in the range of $500-$4,999 for serving as a CARE Consortium Publication Committee Member with Indiana University. Dr. Eckner has received personal compensation in the range of $0-$499 for serving as a Educational Content Contributor with Move United.
Ruchira M. Jha, MD	Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Santosh B. Murthy, MD	Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Iris Katharina Penner, PhD	The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Sandra P. Reyna, MD	Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Rebecca Traub, MD, FAAN	Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext. The institution of Dr. Traub has received research support from Immunovant. The institution of Dr. Traub has received research support from Takeda. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a consultant with Department of Justice.
Edwin S. Vargas, MD	Dr. Vargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Vargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for CSL Berhing.
Jason Viereck, MD, PhD	Dr. Viereck has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Hilde Henon	No disclosure on file
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Jennifer W. McVige, MD, FAAN	Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. The institution of Dr. McVige has received research support from Amgen. The institution of Dr. McVige has received research support from Eli Lily. The institution of Dr. McVige has received research support from Biohaven/Pfizer. The institution of Dr. McVige has received research support from Lundbeck. The institution of Dr. McVige has received research support from Dent Family Foundation. The institution of Dr. McVige has received research support from Abbvie. The institution of Dr. McVige has received research support from Teva. The institution of Dr. McVige has received research support from Theranica. Dr. McVige has a non-compensated relationship as a Neurology Board with UCNS that is relevant to AAN interests or activities. Dr. McVige has a non-compensated relationship as a Board Exam Board Member with ABPN that is relevant to AAN interests or activities.
Thy Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Nguyen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Archana Hinduja, MD	Dr. Hinduja has nothing to disclose.
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Barry A. Hendin, MD, FAAN	Dr. Hendin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Genentech, Genzyme, Novartis ,EMD Serono,Alexion. Dr. Hendin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen., Novartis Genentech, Genzyme, EMD Serono, Alexian. Dr. Hendin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. EMD Serono Genentech Genzyme Novartis Alexian. Dr. Hendin has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Multiple sclerosis association of America. The institution of Dr. Hendin has received research support from Biogen. Genentech.
Sharyl R. Martini, MD, PhD	Dr. Martini has nothing to disclose.
Neepa J. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernius Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Andrew N. Wilner, MD, FACP, FAAN	Dr. Wilner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Wilner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medscape. Dr. Wilner has received publishing royalties from a publication relating to health care.
Aftab Ahmad, MD	Dr. Ahmad has nothing to disclose.
Leonard L. Yeo, MBBS	The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
Pravin George, DO	Dr. George has nothing to disclose.
Alcy Torres, MD	Dr. Torres has nothing to disclose.
Alexis E. Nelson, MD, FAAN	Dr. Nelson has nothing to disclose.
Andrea Almeida, MD	Dr. Almeida has nothing to disclose.
Anup D. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Patel has received research support from PCORI. Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Webinar Development with Medscape. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Other capacity with Guidepoint. Dr. Patel has a non-compensated relationship as a Chair Quality Committee with AAN that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Committee Member with Child Neurology Society that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Board of Directors - member with AAN Institute that is relevant to AAN interests or activities.
Mehyar Mehrizi, MD, FAAN	Dr. Mehrizi has nothing to disclose.
Ahmad Riad Ramadan, MD	Dr. Ramadan has received publishing royalties from a publication relating to health care. Dr. Ramadan has received publishing royalties from a publication relating to health care.
Sarah E. Berini, MD	Dr. Berini has nothing to disclose.
Lixin Zhang, MD, PhD	Dr. Zhang has nothing to disclose.
Alexander Merkler, MD	Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Mehmood Rashid, MD	Dr. Rashid has nothing to disclose.
Sheetal Shroff, MD	Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
E. M. Hoffman, DO, PhD	Dr. Hoffman has nothing to disclose.
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Eddie Jones, BA	Eddie Jones, BA has nothing to disclose.
Maria Petracca, PhD	Dr. Petracca has nothing to disclose.
Tian Ming Tu, MD	Dr. Tu has nothing to disclose.
Veronica E. Santini, MD, MA, FAAN	Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion NeuroStim, Inc. The institution of Dr. Santini has received research support from MeiraGTx, LLC. The institution of Dr. Santini has received research support from Ono Pharmaceuticals. The institution of Dr. Santini has received research support from Lundbeck. The institution of Dr. Santini has received research support from American Parkinson Disease Association. The institution of Dr. Santini has received research support from Mission MSA. The institution of Dr. Santini has received research support from CurePSP. The institution of Dr. Santini has received research support from Parkinson Foundation. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with American Academy of Neurology. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with International Parkinson and Movement Disorders Society. Dr. Santini has received personal compensation in the range of $0-$499 for serving as a invited speaker with Parkinson Study Group. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a data safety monitoring board with NIH.
Daniela Piani Meier	Daniela Piani Meier has received personal compensation for serving as an employee of Novartis Pharma AG.
Elisabeth B. Marsh, MD, FAAN	Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Neurological Association. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN. The institution of Dr. Marsh has received research support from American Heart Association. The institution of Dr. Marsh has received research support from National Institutes of Health. The institution of Dr. Marsh has received research support from National Institutes of Health.
Raymond C. Seet, MD	Dr. Seet has nothing to disclose.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Aarushi Suneja, MD	Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Sara Dawit, MD	Dr. Dawit has nothing to disclose.
Edoardo G. Spinelli, MD	Dr. Spinelli has nothing to disclose.
Giovanna Borriello	Giovanna Borriello has nothing to disclose.
Luigi Lavorgna	Luigi Lavorgna has nothing to disclose.
Michael Barbe	No disclosure on file
Guenther Deuschl, MD, FAAN	Dr. Deuschl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Deuschl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Cavion Functional Neuromodulation. The institution of Dr. Deuschl has received research support from Medtronic. Dr. Deuschl has received publishing royalties from a publication relating to health care.
Eric J. Liebler	Eric J. Liebler has received personal compensation for serving as an employee of electroCore. Eric J. Liebler has received stock or an ownership interest from electroCore.
Roshini Jain	Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Adam S. Jasne, MD	Dr. Jasne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Jeffrey B. Hainsworth, DO	Dr. Hainsworth has stock in Amgen Inc. Dr. Hainsworth has stock in Bristol Myers Squibb Company. Dr. Hainsworth has stock in Johnson & Johnson. Dr. Hainsworth has stock in Medtronic PLC. Dr. Hainsworth has stock in Merck. Dr. Hainsworth has stock in Stryker Corp. Dr. Hainsworth has stock in ABBV.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Neal S. Parikh, MD	Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has or had stock in Alnylam Pharmaceuticals.
Ryan D. Jacobson, MD	Dr. Jacobson has nothing to disclose.
Sung-Min Cho, DO	Dr. Cho has nothing to disclose.
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Marcello Moccia, MD, PhD	Marcello Moccia, 2019 has nothing to disclose.
Antonio Carotenuto	Mr. Carotenuto has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk, Novartis, Roche and Almirall. The institution of Mr. Carotenuto has received research support from ALMIRALL. The institution of Mr. Carotenuto has received research support from Carotenuto Antonio.
Tali R. Sorets	Tali R. Sorets has nothing to disclose.
Benjamin Yong Qiang Tan	Benjamin Yong Qiang Tan has nothing to disclose.
Gianmarco Abbadessa, MD	Dr. Abbadessa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Elisabetta Ferraro, MD	No disclosure on file
Andrew C. Hui, MBBS, FRCP	Dr. Hui has nothing to disclose.
Ava L. Liberman, MD	Dr. Liberman has nothing to disclose.
Stephen A. Johnson, MD	The institution of Dr. Johnson has received research support from ALS Association.
Matthew D. Holtkamp, DO	Dr. Holtkamp has nothing to disclose.
Kamal Shouman, MD	Dr. Shouman has nothing to disclose.
Kate M. Essad, MD, FAAN	Dr. Essad has nothing to disclose.
Steve Kanes, MD, PhD	Dr. Kanes has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Kanes has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Verge Genomics. Dr. Kanes has received intellectual property interests from a discovery or technology relating to health care.
Hui Jin Chiew, MBBS	Dr. Chiew has nothing to disclose.
Neda Sattarnezhad Oskouei, MD	Dr. Sattarnezhad Oskouei has received research support from National Institutes of Health (NIH). Dr. Sattarnezhad Oskouei has received research support from National Institute of Allergy and Infectious Diseases (NIAID).
Christopher Lamb, MD	Dr. Lamb has received research support from Immunovant, Inc.
Smathorn Thakolwiboon, MD	Dr. Thakolwiboon has nothing to disclose.
Silvia Basaia	Silvia Basaia has nothing to disclose.
Jenelle Raynowska, MD	Dr. Raynowska has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Intellisphere, LLC .
Lauren Tardo, MD	Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NeurologyLive. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a consultant with CanDoMS. Dr. Tardo has a non-compensated relationship as a Tardo with The MOG Project that is relevant to AAN interests or activities.
Vishwanath Sagi, MD, FAAN	Dr. Sagi has nothing to disclose.
Michael Popovich, MD	Dr. Popovich has nothing to disclose.
Anastasie M. Dunn-Pirio, MD	Dr. Dunn-Pirio has nothing to disclose.
Andrea Kuehn	Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Mini Singh, MBBS	Dr. Singh has nothing to disclose.
James Doherty, PhD	Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.
Ih Chang	Ih Chang has received personal compensation for serving as an employee of Cerevel. Ih Chang has received stock or an ownership interest from Cerevel Therapeutics.
Aaron Ritter, MD	The institution of Dr. Ritter has received research support from NIH.
Kristy Arbogast	The institution of Kristy Arbogast has received research support from NIH. The institution of Kristy Arbogast has received research support from Pennsylvania Department of Health. The institution of Kristy Arbogast has received research support from Football Research Inc.
Christina Master, MD, FAAP, CAQSM	The institution of Dr. Master has received research support from NIH. The institution of Dr. Master has received research support from DoD. The institution of Dr. Master has received research support from AMSSM. The institution of Dr. Master has received research support from PA Department of Health. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. Dr. Master has received intellectual property interests from a discovery or technology relating to health care.
Marco Pasi	No disclosure on file
Majdi Al Qawasmeh	No disclosure on file
Fei Han	Fei Han has nothing to disclose.
Zheng-Yu Jin	No disclosure on file
Ming-Li Li	No disclosure on file
Jun Ni	Jun Ni has nothing to disclose.
Ming Yao	Ming Yao has nothing to disclose.
Shu-Yang Zhang	No disclosure on file
Paula Hardeman	Ms. Hardeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Ms. Hardeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Korhan Buyukturkoglu, PhD	Dr. Buyukturkoglu has nothing to disclose.
Catherine Hassett, MD	Dr. Hassett has nothing to disclose.
Naga Krishnakanth Madireddy, MD	Dr. Madireddy has nothing to disclose.
Vladimir Bezlyak	Vladimir Bezlyak has received personal compensation for serving as an employee of Novartis Pharma AG. Vladimir Bezlyak has received stock or an ownership interest from Novartis Pharma AG.
Jennifer T. Nguyen, MD	Dr. Nguyen has received research support from Teva Pharmaceuticals LTD.
Marcus Vinicius R. Pinto, MD	Dr. Pinto has nothing to disclose.
Tracy E Madsen	No disclosure on file
Zhiyv Niu, PhD, FACMG	Zhiyv Niu has nothing to disclose.
Stacie L. Demel, DO	Dr. Demel has nothing to disclose.
Akhil Shivaprasad, MBBS	Dr. Shivaprasad has nothing to disclose.
Benzion Blech, MD	Dr. Blech has nothing to disclose.
Shivani Naik, MD	Dr. Naik has nothing to disclose.
Elisabeth Golden, MD	Dr. Golden has nothing to disclose.
Suzanne N. Christie, MD	No disclosure on file
Ann Clark, PharmD	No disclosure on file
Kathryn Nichol, PhD	Dr. Nichol has received personal compensation for serving as an employee of Greenwich Biosciences.
Eva A. Mistry, MD	Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RAPID AI. Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVIe. The institution of Dr. Mistry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silvercreek Pharma. Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for InspireMD. Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi. Dr. Mistry has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Mistry has received research support from National Institutes of Health. The institution of Dr. Mistry has received research support from Patient Centered Outcomes Research Institure.
Brittany L. Heckel, MD	Dr. Heckel has nothing to disclose.
Mariana Vinokur, DO	Dr. Vinokur has nothing to disclose.
Neil Suryadevara, MD	Dr. Suryadevara has nothing to disclose.
Ellen Michelle Gibson, MD	Dr. Gibson has nothing to disclose.
Roberto Alejandro Cruz, MD	The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Nicholas S. Streicher, MD	Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovent. Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Streicher has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Streicher has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Yin-Hsiu Chien	Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avexis/Norvatis. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Yin-Hsiu Chien has received research support from Sanofi Genzyme.
Rashid A. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Hera A. Kamdar, MD	Dr. Kamdar has nothing to disclose.
Joyce A. Jimenez Zambrano, MD	Dr. Jimenez Zambrano has nothing to disclose.
Aparna Nutakki, MD	Ms. Nutakki has received research support from UJMT Fogarty Global Health Fellowship Program. Ms. Nutakki has received research support from AAN Medical Student Research Scholarship. Ms. Nutakki has received research support from Gold Humanism Student Summer Fellowship.
Adib Jorge De Sarachaga, MD	Dr. Jorge De Sarachaga has nothing to disclose.
Hunter L. Mitchell, MD	Dr. Mitchell has nothing to disclose.
Tehniyat Baig, MD	Ms. Baig has nothing to disclose.
Giuseppina Pilloni, PhD	Dr. Pilloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceragem.
Pamela Best	Ms. Best has nothing to disclose.
Li-Ying Cui	No disclosure on file
Stephen Downs	Stephen Downs has stock in Digital Health Solutions. The institution of Stephen Downs has received research support from Child Neurology Foundation.
Zi-Yue Liu	Zi-Yue Liu has nothing to disclose.
Youngran Kim	Ms. Kim has nothing to disclose.
Camilla Cividini, MSc	Ms. Cividini has nothing to disclose.
Rumyar V. Ardakani, MD	Dr. Ardakani has nothing to disclose.
Celia Linton Walker, MHA	Ms. Linton Walker has nothing to disclose.
Lynda Nwabuobi, MD	Dr. Nwabuobi has received personal compensation in the range of $0-$499 for serving as a Consultant for KX Advisors. Dr. Nwabuobi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Healthgrades. Dr. Nwabuobi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consultant 360.
Manon Auffret, PhD, PharmD, DAAN	Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aguettant. The institution of Dr. Auffret has received research support from Oxylis Medical. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Ryan J. Case, PhD	Dr. Case has received personal compensation for serving as an employee of NeuroDerm.
Courtney Seebadri-White, MD	Dr. Seebadri-White has nothing to disclose.
Irma N. Duncan, MD	Dr. Duncan has nothing to disclose.
Zahari Tchopev, MD	Dr. Tchopev has nothing to disclose.
Maria Cellerino, MD	Maria Cellerino has nothing to disclose.
Mattia Rosso, MD	Dr. Rosso has nothing to disclose.
Joanne M. Wagner, PhD, PT	Dr. Wagner has received personal compensation for serving as an employee of Xenon Pharmaceuticals, Inc.. Dr. Wagner has stock in Biogen. Dr. Wagner has stock in Xenon Pharmaceuticals, Inc..
Paige Buddenhagen	No disclosure on file
Tamar Yardeni	Tamar Yardeni has received personal compensation for serving as an employee of Neuroderm.
Zarmina Mufti, MD	Dr. Mufti has nothing to disclose.
John R. Mills, MD, PhD	The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Shahar Shelly, MD	Dr. Shelly has or had stock in Remepy.
Steffen Paschen	The institution of Steffen Paschen has received research support from Deutsche Forschungsgemeinschaft. The institution of Steffen Paschen has received research support from Parkinsonfonds. The institution of Steffen Paschen has received research support from UCB .
Feifei Zhai	No disclosure on file
Sarah Wrigley, MD	Dr. Wrigley has nothing to disclose.
Aaron Shoskes, DO	Dr. Shoskes has nothing to disclose.
Hisham Alhajala, MD	Dr. Alhajala has nothing to disclose.
Justin Rosati, MD	Dr. Rosati has nothing to disclose.
Jennifer H. Yang, MD	Dr. Yang has received research support from Pediatric Epilepsy Research Foundation. Dr. Yang has received research support from NIH.
Belal A. Aldabbour, MD	Dr. Aldabbour has nothing to disclose.
Anna L. Bazan, MD	Dr. Bazan has nothing to disclose.
Sitra Tauscher-Wisniewski	Sitra Tauscher-Wisniewski has received personal compensation for serving as an employee of Novartis Gene Therapies.
Aaron Koenig	Aaron Koenig has received personal compensation for serving as an employee of Sage Therapeutics.
Jie Pan, MD	Dr. Pan has nothing to disclose.
Mathieu Rutgers	No disclosure on file
Janette Contreras-De Lama	Janette Contreras-De Lama has received personal compensation for serving as an employee of AbbVie. Janette Contreras-De Lama has stock in AbbVie.
Jasmine Koh, MBBS	Dr. Koh has nothing to disclose.
Ming Hui Yong, MD	Dr. Yong has nothing to disclose.
Victor Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Christina Xia, MD	Dr. Xia has nothing to disclose.
Burkhard Blank	Burkhard Blank has received personal compensation for serving as an employee of Acorda Therapeutics. Burkhard Blank has received stock or an ownership interest from Acorda Therapeutics, Inc.
Aron Gedansky, MD	Dr. Gedansky has nothing to disclose.
Mustafa Al-Chalabi, DO	Dr. Al-Chalabi has nothing to disclose.
Merry Huang, MD	Dr. Huang has nothing to disclose.
Melody Badii, MD	Dr. Badii has nothing to disclose.
Busranur Agac, MD	Dr. Agac has nothing to disclose.
Elizabeth Leon	Elizabeth Leon has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for BIOGEN AND SANOFI.
Yihui Goh, MBBS	Dr. Goh has nothing to disclose.
Rebecca Hoe, MBBS, MRCP	Dr. Hoe has nothing to disclose.
Enrique Carrazana	Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Liat Adar	Liat Adar has received personal compensation for serving as an employee of Neuroderm.
Patricia R. Roby, PhD	The institution of Dr. Roby has received research support from NIH.
Isabel Siow	Ms. Siow has nothing to disclose.
Rachel Gorenflo	Rachel Gorenflo has nothing to disclose.
Yongsheng Chen, PhD	Dr. Chen has nothing to disclose.
Soo-Hyun Kim, MD	Dr. Kim has nothing to disclose.
Hyung Ho Kim, MD	Dr. KIM has nothing to disclose.
Guogen Shan, PhD	Dr. Shan has nothing to disclose.
Stephen A. Berman, MD	Dr. Berman has received research support from University of Central Florida.
Lance Fogan, MD, FAAN	Dr. Fogan has nothing to disclose.
Rose A. Giammarco, MD	Dr. Giammarco has nothing to disclose.
Sherry R. Danese	No disclosure on file
Elizabeth Leroux, MD	Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Innovation Canada. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Leroux has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie /Allergan. Dr. Leroux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lin Pharmaceutical. Dr. Leroux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Leroux has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Leroux has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Leroux has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer.
Traci B. Schilling, MD	Dr. Schilling has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Schilling has or had stock in Eli Lilly and Company.
Aryeh Zolin, MD, PhD	Dr. Zolin has nothing to disclose.
Virginia DeLasHeras	Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Ghazal Banisadr, PhD	Dr. Banisadr has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Joy Lin, MD	Dr. Lin has nothing to disclose.
Matthew Leoni, MD, MBA	Dr. Leoni has received personal compensation for serving as an employee of Cerevel Therapeutics.
Lindsay Frerichs, MD	Dr. Frerichs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Frerichs has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Headache Society.
Jenifer Patterson, NP	Ms. Patterson has received personal compensation for serving as an employee of Greenwich Biosciences .
Jorge A. Cespedes	Mr. Cespedes has nothing to disclose.
Francois Cadiou, MBA	Mr. Cadiou has received personal compensation for serving as an employee of Healint.
Evan Madill, MD	The institution of Dr. Madill has received research support from American Academy of Neurology.
Dargelis Chi, MD	Dr. Chi has nothing to disclose.
Xiaoyang Li, MD	Dr. Li has nothing to disclose.
Jennifer Amsdell, MD	Dr. Amsdell has nothing to disclose.
Moe P. Shwe, MBBS, MMedSc, MRCP	Dr. Shwe has nothing to disclose.
Jonathan Davidow, MD	Dr. Davidow has nothing to disclose.
Minseon Kim, MD	Dr. Kim has nothing to disclose.
Lina Chervak, MD	Dr. Chervak has nothing to disclose.
Cori A. Cummings, MD	Dr. Cummings has nothing to disclose.
Raja Godasi, MBBS	Dr. Godasi has nothing to disclose.
Ada Breitenbucher, MD	Dr. Breitenbucher has nothing to disclose.
Sanem P. Uysal, MD	Dr. Uysal has nothing to disclose.
Mays Khweileh, Jr., MD	Dr. Khweileh has nothing to disclose.
Youssra H. Saqr, MD	Dr. Saqr has nothing to disclose.
Natacha Bastien	Natacha Bastien has received personal compensation for serving as an employee of Novartis Canada Pharma.
Relfa Proano, MD	Dr. Proano has nothing to disclose.
Chenel Morrison	Miss Morrison has nothing to disclose.
Rebecca A. Silverstein, DO	Dr. Silverstein has nothing to disclose.
Ahmed Ibrahim, MBBCH	Dr. Ibrahim has nothing to disclose.
Navreet Kaur, MBBS	Dr. Kaur has nothing to disclose.
Roberto Hernandez Quintana, MD	Dr. Hernandez Quintana has nothing to disclose.
Deep Patel, MD	Dr. Patel has nothing to disclose.
Xue Yang, MD, PhD	Dr. Yang has nothing to disclose.
Andrew J. Carlson, MD	Mr. Carlson has nothing to disclose.
Harshadayani Jagadish Kumar, MBBS	Dr. Jagadish Kumar has nothing to disclose.
Carolyn Parsey, PhD	Dr. Parsey has received research support from NIH/NINDS. Dr. Parsey has received research support from Ellison Foundation.
Magdalena Lana	Miss Lana has nothing to disclose.
Ademilola Tejuoso	Ms. Tejuoso has nothing to disclose.
Sherry Danese	No disclosure on file
Hamza Chaudhry	Dr. Chaudhry has nothing to disclose.
Emily Dvorak	Ms. Dvorak has nothing to disclose.
Erik Seroogy	Mr. Seroogy has nothing to disclose.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Arseniy Lavrov	Dr. Lavrov has received personal compensation for serving as an employee of Novartis. Dr. Lavrov has stock in Novartis.
Ayatalla Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Darshini Shah, Other	Ms. Shah has received personal compensation for serving as an employee of AbbVie. Ms. Shah has stock in AbbVie Inc. An immediate family member of Ms. Shah has received research support from National Institutes of Health.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Rishika Singh	Ms. Singh has nothing to disclose.
Elma Chowdhury	Ms. Chowdhury has nothing to disclose.
Michelle Pang	Ms. Pang has received research support from National Institue of Health.
Julia Sumera	Miss Sumera has nothing to disclose.
Karen Stephenson	Ms. Stephenson has nothing to disclose.
Maxwell G. Kahn	Mr. Kahn has nothing to disclose.
Haneen F. Al Refa'i	Ms. Al Refa'i has nothing to disclose.
Gina Pastino, PhD	Dr. Pastino has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Pastino has received personal compensation for serving as an employee of PRA Health Sciences.
Catarina Aragon Pinto, MD	Dr. Aragon Pinto has nothing to disclose.
Driss Rochdi, PhD	Mr. Rochdi has received personal compensation for serving as an employee of Novartis.
Alexis Ahmad	No disclosure on file
David Gray	David Gray has received personal compensation for serving as an employee of Vigil. David Gray has received personal compensation for serving as an employee of Inscopix. David Gray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil. David Gray has stock in Vigil.
Stacey Versavel, PhD	Dr. Versavel has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Versavel has received stock or an ownership interest from Cerevel Therapeutics.
Antonia Wang	No disclosure on file